1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Coenzyme Q10 (CoQ10) Market Analysis By Application (Dietary Supplements, Pharmaceuticals, Cosmetics) And Segment Forecasts To 2020

Coenzyme Q10 (CoQ10) Market Analysis By Application (Dietary Supplements, Pharmaceuticals, Cosmetics) And Segment Forecasts To 2020

  • May 2016
  • -
  • Grand View Research
  • -
  • 67 pages

Summary

Table of Contents

The global CoQ10 market is expected to reach USD 849.5 million by 2020. Growth of personal care industry particularly in BRIC nations is expected to remain a key driving factor for the global CoQ10 market. Increasing penetration of CoQ10 in medical industry is also expected to have positive influence on market growth. Constantly fluctuating CoQ10 prices is expected to remain a key challenge for market participants over the forecast period.

Dietary supplements emerged as the leading application for CoQ10 and accounted for 59.9% of total market volume in 2013. Increasing health concerns is expected to drive the demand for antioxidants and energy supplements which in turn is expected to drive CoQ10 demand over the next six years. Pharmaceutical is expected to be the most lucrative application segment and is expected to grow at an estimated CAGR of 9.9% from 2014 to 2020. Cardiac benefits of CoQ10 coupled with increasing prevalence of cardiovascular diseases across the globe are major factors driving its demand in pharmaceutical applications.

Further key findings from the study suggest:

Global CoQ10 market demand was 624.8 kilo tons in 2013 and is expected to reach 1,168 kilo tons by 2020, growing at a CAGR of 9.2% from 2014 to 2020.
North America was the largest regional market for CoQ10 and accounted for over half of total market volume in 2013. Increasing application of CoQ10 in cosmetics such as anti-ageing and sunscreen lotions particularly in the U.S. is expected to drive the regional market. Non recognition of CoQ10 in pharmaceuticals by U.S. FDA is expected to remain a key challenge for the regional market.
Asia Pacific is expected to witness highest growth rate over the next six years. The region is expected to grow at an estimated CAGR of 10.1% from 2014 to 2020. Growth of major end-use industries such as pharmaceuticals and cosmetics particularly in emerging markets of China and India is expected to drive the regional CoQ10 market. Increasing health awareness is also expected to have a positive influence on regional CoQ10 demand.
The global CoQ10 market witnessed drop in prices from 2009 to 2014 on account of emergence of large number of local manufacturers in China. The prices are expected to increase over the forecast period owing to the exit of Mitsubishi Gas Chemical Co. from the market which has substantially limited supply.
Some of the major companies operating the global market include ZMC-USA, Kaneka Corporation, Gnosis S.p.A., DSM Nutritional Products, PharmaEssentiA Corporation and Xiamen Kingdomway Co.
For the purpose of this study, Grand View Research has segmented the CoQ10 market on the basis of application and region:

Global CoQ10 Application Outlook (Volume, Tons; Revenue, USD Million, 2012 - 2020)
- Dietary Supplements
- Pharmaceuticals
- Cosmetics
- Others
Global CoQ10 Regional Outlook (Volume, Tons; Revenue, USD Million, 2012 - 2020)
- North America
- Europe
- Asia Pacific
- RoW

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
Get This Report
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
2017 World Clinical Chemistry Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East—Over 100 Special Chemistry, Abused Drugs, Endocrine, Immunoprotein, TDM, Tumor MarkerTests--Supplier Shares, Competitive Strategies, Opportunities

2017 World Clinical Chemistry Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East—Over 100 Special Chemistry, Abused Drugs, Endocrine, Immunoprotein, TDM, Tumor MarkerTests--Supplier Shares, Competitive Strategies, Opportunities

  • $ 75000
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com provides a granular strategic analysis of over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays performed in both ...

2017 World Cancer Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

2017 World Cancer Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

  • $ 52400
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding cancer diagnostic ...

2017 World Tumor Marker Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

2017 World Tumor Marker Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

  • $ 52400
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding cancer diagnostic ...


ref:plp2016

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.